Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking. (2019)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/c9sc02079a
PubMed Identifier: 32015811
Publication URI: http://europepmc.org/abstract/MED/32015811
Type: Journal Article/Review
Volume: 10
Parent Publication: Chemical science
Issue: 42
ISSN: 2041-6520